Showing results (111-120 of 373) with videos related to

Sort By:
Pageof 38
JCO Precision Oncology|March 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisCharles Swanton, Alan Bryce, Allen L Cohn, et al.
Lancet (London, England)|September 7, 2016
Challenges in molecular testing in non-small-cell lung cancer patients with advanced diseaseCrispin T Hiley, John Le Quesne, George Santis, et al.
The Lancet. Oncology|June 9, 2017
Evolving adoptive cellular therapies in urological malignanciesYien Ning Sophia Wong, Kroopa Joshi, Martin Pule, et al.
Genome Biology|June 13, 2025
Cancer gene identification from RNA variant allelic frequencies using RVdriverJames R M Black, Thomas P Jones, Carlos Martínez-Ruiz, et al.
Nature|March 19, 2026
Thymic health and immunotherapy outcomes in patients with cancerSimon Bernatz, Vasco Prudente, Suraj Pai, et al.
Cancers|October 14, 2022
Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled TrialRichard D Neal, Peter Johnson, Christina A Clarke, et al.
Cancer Research|June 28, 2014
Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancerDavid Endesfelder, Rebecca Burrell, Nnennaya Kanu, et al.
Breast (Edinburgh, Scotland)|April 5, 2015
New approaches for improving outcomes in breast cancer in EuropeAngelo Di Leo, Giuseppe Curigliano, Véronique Diéras, et al.
Plos One|December 15, 2010
Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER statusQiyuan Li, Aron C Eklund, Nicolai Juul, et al.
JCO Precision Oncology|April 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical TrialsRafael Grochot, Kroopa Joshi, Antonella Cammarota, et al.
Pageof 38